• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米颗粒辅助的肽类癌症疫苗递送

Nanoparticles-Assisted Peptide Cancer Vaccine Delivery.

作者信息

Luo Lanqing, Kuai Rui

机构信息

School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.

Tsinghua-Peking Center for Life Sciences, Beijing, China.

出版信息

Methods Mol Biol. 2025;2926:129-141. doi: 10.1007/978-1-0716-4542-0_10.

DOI:10.1007/978-1-0716-4542-0_10
PMID:40266522
Abstract

Efficient delivery of tumor antigen peptides and adjuvants to dendritic cells in lymphoid organs is critical for eliciting potent tumor antigen-specific CD8+ T cell responses. However, soluble antigens and adjuvants often suffer from rapid clearance and fail to induce strong T-cell responses. Synthetic high-density lipoproteins (sHDL) nanodiscs, which are 10-nm discoidal nanoparticles, have been shown to facilitate the co-delivery of peptide antigens and adjuvants to lymph nodes and induce strong and durable antigen presentation by dendritic cells, which markedly improve the overall magnitude of antigen-specific T cell responses. Here we summarize the methods for preparing sHDL-based peptide cancer vaccines and protocols for analyzing the T cell responses against different tumor antigens. We envision that these methods will be helpful in developing and assessing other nanoparticle-based peptide cancer vaccines in the future.

摘要

将肿瘤抗原肽和佐剂有效递送至淋巴器官中的树突状细胞,对于引发强大的肿瘤抗原特异性CD8+ T细胞反应至关重要。然而,可溶性抗原和佐剂常常会迅速清除,无法诱导强烈的T细胞反应。合成高密度脂蛋白(sHDL)纳米盘是直径为10纳米的盘状纳米颗粒,已被证明可促进肽抗原和佐剂共同递送至淋巴结,并诱导树突状细胞进行强大且持久的抗原呈递,这显著提高了抗原特异性T细胞反应的整体强度。在此,我们总结了基于sHDL的肽癌症疫苗的制备方法以及分析针对不同肿瘤抗原的T细胞反应的方案。我们设想,这些方法将有助于未来开发和评估其他基于纳米颗粒的肽癌症疫苗。

相似文献

1
Nanoparticles-Assisted Peptide Cancer Vaccine Delivery.纳米颗粒辅助的肽类癌症疫苗递送
Methods Mol Biol. 2025;2926:129-141. doi: 10.1007/978-1-0716-4542-0_10.
2
Extending antigen release from particulate vaccines results in enhanced antitumor immune response.延长微粒状疫苗的抗原释放可增强抗肿瘤免疫应答。
J Control Release. 2018 Jan 10;269:393-404. doi: 10.1016/j.jconrel.2017.11.020. Epub 2017 Nov 13.
3
Cross-Linked Peptide Nanoclusters for Delivery of Oncofetal Antigen as a Cancer Vaccine.交联肽纳米簇作为癌症疫苗传递肿瘤胚胎抗原。
Bioconjug Chem. 2018 Mar 21;29(3):776-785. doi: 10.1021/acs.bioconjchem.8b00079. Epub 2018 Feb 13.
4
Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8 T Cell Responses.基于肽的纳米疫苗设计,针对妇科癌症的主要抗原,诱导 HLA-A2.1 限制性 CD8 T 细胞反应。
Front Immunol. 2018 Dec 21;9:2968. doi: 10.3389/fimmu.2018.02968. eCollection 2018.
5
Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.外泌体作为有效的无细胞肽基疫苗。I. 树突状细胞衍生的外泌体将功能性MHC I类/肽复合物转移至树突状细胞。
J Immunol. 2004 Feb 15;172(4):2126-36. doi: 10.4049/jimmunol.172.4.2126.
6
Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity.工程化嵌合肽介导的肽抗原和佐剂共递呈至抗原呈递细胞增强抗肿瘤 T 细胞免疫。
Cancer Immunol Res. 2024 Jul 2;12(7):905-920. doi: 10.1158/2326-6066.CIR-23-0926.
7
Vaccine nanodiscs plus polyICLC elicit robust CD8+ T cell responses in mice and non-human primates.疫苗纳米盘加聚肌苷酸胞苷酸在小鼠和非人灵长类动物中引发强烈的 CD8+T 细胞反应。
J Control Release. 2021 Sep 10;337:168-178. doi: 10.1016/j.jconrel.2021.07.026. Epub 2021 Jul 16.
8
Antigen self-presenting dendrosomes swallowing nanovaccines boost antigens and STING agonists codelivery for cancer immunotherapy.抗原自呈递树突体吞噬纳米疫苗增强抗原和STING激动剂共递送用于癌症免疫治疗。
Biomaterials. 2025 May;316:122998. doi: 10.1016/j.biomaterials.2024.122998. Epub 2024 Dec 9.
9
CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses.载药 PLGA 纳米粒疫苗经 CD40 靶向树突状细胞投递诱导强烈的抗肿瘤反应。
Biomaterials. 2015 Feb;40:88-97. doi: 10.1016/j.biomaterials.2014.10.053. Epub 2014 Nov 26.
10
Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine development.铁蛋白蛋白笼纳米颗粒作为多功能抗原递呈纳米平台,用于树突状细胞(DC)为基础的疫苗开发。
Nanomedicine. 2014 Apr;10(3):561-9. doi: 10.1016/j.nano.2013.11.003. Epub 2013 Nov 18.

本文引用的文献

1
Designing spatial and temporal control of vaccine responses.设计疫苗反应的时空控制。
Nat Rev Mater. 2022;7(3):174-195. doi: 10.1038/s41578-021-00372-2. Epub 2021 Sep 28.
2
Controlling timing and location in vaccines.控制疫苗的时间和地点。
Adv Drug Deliv Rev. 2020;158:91-115. doi: 10.1016/j.addr.2020.06.019. Epub 2020 Jun 26.
3
Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy.双 TLR 激动剂纳米盘作为疫苗和免疫疗法的强佐剂系统。
J Control Release. 2018 Jul 28;282:131-139. doi: 10.1016/j.jconrel.2018.04.041. Epub 2018 Apr 25.
4
Subcutaneous Nanodisc Vaccination with Neoantigens for Combination Cancer Immunotherapy.皮下纳米盘免疫接种新抗原用于联合癌症免疫治疗。
Bioconjug Chem. 2018 Mar 21;29(3):771-775. doi: 10.1021/acs.bioconjchem.7b00761. Epub 2018 Feb 27.
5
Designer vaccine nanodiscs for personalized cancer immunotherapy.设计用于个性化癌症免疫治疗的疫苗纳米盘。
Nat Mater. 2017 Apr;16(4):489-496. doi: 10.1038/nmat4822. Epub 2016 Dec 26.
6
High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.高密度脂蛋白:天然的多功能纳米颗粒。
ACS Nano. 2016 Mar 22;10(3):3015-41. doi: 10.1021/acsnano.5b07522. Epub 2016 Feb 25.
7
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.一种从小鼠骨髓中生成大量高纯度树突状细胞的先进培养方法。
J Immunol Methods. 1999 Feb 1;223(1):77-92. doi: 10.1016/s0022-1759(98)00204-x.